Product NDC: | 52268-012 |
Proprietary Name: | SUPREP Bowel Prep |
Non Proprietary Name: | sodium sulfate, potassium sulfate, magnesium sulfate |
Active Ingredient(s): | 1.6; 3.13; 17.5 g/mL; g/mL; g/mL & nbsp; sodium sulfate, potassium sulfate, magnesium sulfate |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION, CONCENTRATE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52268-012 |
Labeler Name: | Braintree Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022372 |
Marketing Category: | NDA |
Start Marketing Date: | 20100806 |
Package NDC: | 52268-012-01 |
Package Description: | 2 BOTTLE, PLASTIC in 1 CARTON (52268-012-01) > 177.4 mL in 1 BOTTLE, PLASTIC |
NDC Code | 52268-012-01 |
Proprietary Name | SUPREP Bowel Prep |
Package Description | 2 BOTTLE, PLASTIC in 1 CARTON (52268-012-01) > 177.4 mL in 1 BOTTLE, PLASTIC |
Product NDC | 52268-012 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | sodium sulfate, potassium sulfate, magnesium sulfate |
Dosage Form Name | SOLUTION, CONCENTRATE |
Route Name | ORAL |
Start Marketing Date | 20100806 |
Marketing Category Name | NDA |
Labeler Name | Braintree Laboratories, Inc. |
Substance Name | MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE |
Strength Number | 1.6; 3.13; 17.5 |
Strength Unit | g/mL; g/mL; g/mL |
Pharmaceutical Classes | Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA] |